Combining LSD1 and JAK-STAT inhibition targets Down syndrome-associated myeloid leukemia at its core.

ABSTRACT:

SUBMITTER: Grimm J 

PROVIDER: S-EPMC9252908 | biostudies-literature | 2022 Jul

REPOSITORIES: biostudies-literature